Survivin Inhibition Reverses Cardiac and Pulmonary Remodeling in Monocrotaline-Induced Pulmonary Arterial Hypertension

被引:0
|
作者
Ferreira-Pinto, Manuel J. [1 ]
Silva, Ana Filipa [1 ]
Justino, Joana [2 ]
Nogueira-Ferreira, Rita [2 ]
Padrco, Ana Isabel [2 ]
Moreira-Goncalves, Daniel [1 ]
Carneiro, Fabio [1 ]
Costa, Raquel [3 ]
Leite-Moreira, Adelino F. [1 ]
Henriques-Coelho, Tiago [1 ]
机构
[1] Univ Porto, Dept Physiol & Cardiothorac Surg, Fac Med, P-4100 Oporto, Portugal
[2] Univ Aveiro, Dept Chem, P-3800 Aveiro, Portugal
[3] Univ Porto, Dept Biochem, Fac Med, P-4100 Oporto, Portugal
关键词
Pulmonary heart disease; Apoptosis; Cardiac hypertrophy; Muscle; smooth;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
13156
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Modulation of survivin reverses cardiac and pulmonary remodeling in monocrotaline-induced pulmonary arterial hypertension
    Ana Filipa Silva, A. F.
    Ferreira-Pinto, M. J.
    Justino, J.
    Nogueira-Ferreira, R.
    Padrao, A. I.
    Carneiro, F.
    Moreira-Goncalves, D.
    Leite-Moreira, A. F.
    Henriques-Coelho, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 30 - 31
  • [2] Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension
    Jung, Christian
    Gruen, Katja
    Betge, Stefan
    Pernow, John
    Kelm, Malte
    Muessig, Johanna
    Masyuk, Maryna
    Kuethe, Friedhelm
    Ndongson-Dongmo, Bernadin
    Bauer, Reinhard
    Lauten, Alexander
    Schulze, P. Christian
    Berndt, Alexander
    Franz, Marcus
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (08)
  • [3] Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats
    Price, L. C.
    Montani, D.
    Tcherakian, C.
    Dorfmueller, P.
    Souza, R.
    Gambaryan, N.
    Chaumais, M-C.
    Shao, D. M.
    Simonneau, G.
    Howard, L. S.
    Adcock, I. M.
    Wort, S. J.
    Humbert, M.
    Perros, F.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (04) : 813 - 822
  • [4] Gp130 inhibitor reduces inflammation and reverses pulmonary arterial remodeling of monocrotaline-induced pulmonary arterial hypertension
    Huang, Z. W.
    Liu, Z. H.
    Luo, Q.
    Zhao, Z. H.
    Zhao, Q.
    Zheng, Y. G.
    Xi, Q. Y.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1062 - 1062
  • [5] Safflower injection inhibits pulmonary arterial remodeling in a monocrotaline-induced pulmonary arterial hypertension rat model
    Chen, Aifeng
    Ding, Shibiao
    Kong, Liangliang
    Xu, Jianpu
    He, Fei
    Ru, Chuhui
    Lin, Xu'ai
    ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES, 2021, 76 (1-2): : 27 - 34
  • [6] Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats
    Guignabert, C
    Raffestin, B
    Benferhat, R
    Raoul, W
    Zadigue, P
    Rideau, D
    Hamon, M
    Adnot, S
    Eddahibi, S
    CIRCULATION, 2005, 111 (21) : 2812 - 2819
  • [7] Cardiac Glycolytic Metabolism In Monocrotaline-Induced Pulmonary Arterial Hypertension Rats
    Qiu, M. -H.
    Zhang, R.
    Zhang, H. -D.
    Jiang, X.
    Liu, D.
    Jing, Z. -C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [8] Inhibition of ubiquitin proteasome function prevents monocrotaline-induced pulmonary arterial remodeling
    Zhu, Yanting
    Wu, Yinxia
    Shi, Wenhua
    Wang, Jian
    Yan, Xin
    Wang, Qingting
    Liu, Ya
    Yang, Lan
    Gao, Li
    Li, Manxiang
    LIFE SCIENCES, 2017, 173 : 36 - 42
  • [9] Formononetin attenuates monocrotaline-induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats
    Cai, Changhong
    Xiang, Yijia
    Wu, Yonghui
    Zhu, Ning
    Zhao, Huan
    Xu, Jian
    Lin, Wensheng
    Zeng, Chunlai
    MOLECULAR MEDICINE REPORTS, 2019, 20 (06) : 4984 - 4992
  • [10] Astragaloside IV blocks monocrotaline-induced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling
    Jin, Haifeng
    Jiao, Yu
    Guo, Linna
    Ma, Yong
    Zhao, Rongjie
    Li, Xuemei
    Shen, Lei
    Zhou, Zhongguang
    Kim, Sang Chan
    Liu, Jicheng
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2021, 47 (02) : 595 - 606